This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

Cardiovascular

AI read chest radiographs help to identify severe CAD
AI read chest radiographs help to identify severe CAD
Read more
ECG and radiomics model enhance detection of AF in women
ECG and radiomics model enhance detection of AF in women
Read more
Olpasiran substantially reduces lipoprotein A levels in cardiovascular disease patients
Olpasiran substantially reduces lipoprotein A levels in cardiovascular disease patients
Read more
Study suggests thyroid cancer increases coronary heart disease risk
Study suggests thyroid cancer increases coronary heart disease risk
Read more
Higher plant omega-3 levels reduce death and hospitalisation risk in heart failure
Higher plant omega-3 levels reduce death and hospitalisation risk in heart failure
Read more
Adverse cardiovascular outcomes higher in patients hospitalised with COVID-19
Adverse cardiovascular outcomes higher in patients hospitalised with COVID-19
Read more
Misuse of illicit substances linked to higher risk of atrial fibrillation
Misuse of illicit substances linked to higher risk of atrial fibrillation
Read more
Blood pressure medicine dosing time does not affect adverse CV outcomes
Blood pressure medicine dosing time does not affect adverse CV outcomes
Read more
Shift workers use of time-restricted eating and cardiometabolic health
Shift workers use of time-restricted eating and cardiometabolic health
Read more
Hypothermic temperature control following in-hospital cardiac arrest
Hypothermic temperature control following in-hospital cardiac arrest
Read more
Heart failure patients benefit from telemedicine
Heart failure patients benefit from telemedicine
Read more
Bionic pancreas improves glycated haemoglobin level in type 1 diabetics
Bionic pancreas improves glycated haemoglobin level in type 1 diabetics
Read more
AI-guided screening improves detection of atrial fibrillation
AI-guided screening improves detection of atrial fibrillation
Read more
P2Y12 inhibitor mono-therapy after PCI
P2Y12 inhibitor mono-therapy after PCI
Read more
Weight-lifting and cardiovascular disease mortality
Weight-lifting and cardiovascular disease mortality
Read more

Popular articles

Government commits to easing pressure on NHS through commercial clinical trial investment
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
Understanding the intricacies of tube feeding with Stephen Taylor





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora